Joshua Dean Kreimeyer PLPC

Recommended Articles

• Is There a Link Between Obstructive Sleep Apnea and Speech?

  Many patients experience issues in speech when diagnosed with sleep apnea. The altered speech function in OSA has led researchers to believe that there is an underlying link between obstructive sleep apnea and a speech disorder. It has been seen in both children and adults, especially if they have...

• Sandra Lee, Breast Cancer Survivor, Wants You to be Neurotic About Your Health

  October is referred to in the United States as National Breast Cancer Awareness Month. In honor of the annual campaign dedicated to raising awareness of the disease, Sandra Lee’s documentary short - “RX Early Detection: A Cancer Journey with Sandra Lee” - is filled with wry humor, tears, and...

• What Primary Care Providers Need to Know About Ovarian Cancer

  In the United States, there will be 22,440 women diagnosed with ovarian cancer in 2017 and over half of those cases will be fatal, according to the American Cancer Society. For women, ovarian cancer is the fifth leading cause of cancer deaths. And a woman’s risk of developing ovarian cancer in her...

• Neighborhood Star Tichina Arnold Is an Advocate for the Fight Against Lupus

  The 16th annual Hollywood Bag Ladies Luncheon was held in LA in November and designer handbags from Prada, Gucci, Chanel, Roberto Cavalli, and Prada were featured at the event to award “Neighborhood” star Tichina Arnold and her sister Zenay with the non-profits' Women of the Year Achievement...

• Medicare Provider Incentives May Lead to Reduction of Type 2 Diabetes

  Public health and the access to medical care for the impoverished or for those who have lower than average incomes have always been a subject of controversy in the United States. However, in the past few years, increased government investment in this sector have made proper healthcare available for...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...